
Venclexta
My Prescription
Payment
Select pharmacy



$3,881.51
$30.00 due at pharmacy
$3,881.51 - $30.00 = $3,851.51
$3,851.51 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$3,881.51
Print or send this coupon to your phone
About Venclexta
Drug Details
Venetoclax, marketed under the name Venclexta, is a medication primarily used to treat certain blood and lymph node cancers such as acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL). It is particularly prescribed for older adults or individuals with specific medical conditions. This medication is typically taken orally once a day, either alone or alongside other chemotherapy or targeted treatments, depending on the patient's specific condition. Venclexta operates as a targeted therapy known as a BCL-2 inhibitor. The BCL-2 protein aids in the survival of cancer cells, and certain cancers, including AML and CLL/SLL, are characterized by an overproduction of this protein, leading to uncontrolled cell growth. By blocking BCL-2, venetoclax helps to kill and slow the growth of these cancer cells, effectively managing the disease. Patients should be aware that venetoclax can increase the risk of a serious condition known as tumor lysis syndrome (TLS). It is crucial to engage with healthcare professionals, such as doctors, nurses, or pharmacists, to receive personalized medical advice and ensure the medication's safe and effective use.
Price history for Venclexta
28 Tablets, 100MG
Average retail price for Venclexta
Average SaveHealth price for Venclexta
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Venclexta dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 10MG | 2 Tablets | $33.83 | $16.92 |
| 10MG | 14 Tablets | $200.74 | $14.34 |
| 50MG | 1 Tablet | $75.60 | $75.60 |
| 50MG | 7 Tablets | $492.30 | $70.33 |
| 100MG | 28 Tablets | $3,881.51 | $138.63 |
| 100MG | 1 Tablet | $145.15 | $145.15 |
| 100MG | 120 Tablets | $16,608.75 | $138.41 |
Venclexta FAQs
VENCLEXTA (venetoclax) is not considered traditional chemotherapy. It is a targeted therapy known as a BCL-2 inhibitor, which works by helping to restore the process of apoptosis, or programmed cell death, in cancer cells.
VENCLEXTA is used for the treatment of certain types of blood cancers, specifically chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML). It works by targeting and inhibiting a protein that helps cancer cells survive, thereby promoting their destruction.
VENCLEXTA (venetoclax) is not classified as an immunosuppressant. It is a medication used primarily in the treatment of certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by inhibiting a protein called BCL-2, which helps cancer cells survive.
The life expectancy of patients taking VENCLEXTA (venetoclax) can vary significantly based on several factors, including the type and stage of cancer being treated, the patient's overall health, response to treatment, and other individual circumstances. Clinical trials and studies provide data on progression-free survival and overall survival rates, but these are averages and may not predict individual outcomes. It is important for patients to discuss their specific prognosis with their healthcare provider, who can provide information tailored to their unique situation.
Venetoclax is not classified as an immunosuppressant. It is a medication used primarily in the treatment of certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by inhibiting the BCL-2 protein, which helps cancer cells survive.